China Pharma logo
China Pharma
CPHI | AMEX
Chart Builder DCF Calculator
$0.48
-$0.04 (-7.35%)
At close: Nov 16, 2026, 3:58 PM ET
$0.50
+$0.02 (+4.17%)
After-hours: Nov 16, 2026, 7:07 PM ET

China Pharma Cash Flow Statement

Cash flow statement explained
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-4.47M -3.55M -3.19M -3.19M -3.66M -4.57M -4.74M -4.74M -4.4M -3.56M -3.08M -3.11M -3.12M -3.42M -3.97M -3.69M -3.73M -3.66M -3.4M -3.63M -3.81M -2.97M
3.05M 2.23M 1.58M 1.45M 1.8M 2.21M 2.62M 2.87M 2.85M 2.81M 2.75M 2.7M 2.68M 2.67M 2.7M 2.77M 3.08M 3.1M 3.09M 3.08M 2.78M 2.72M
– – – – – – – – – – – 78.27K 78.27K 78.27K 78.27K – – – – – – –
631.91K 508.82K 421.44K 872.89K 755.68K 805.02K 520.23K 146.87K 646.82K 593.34K 246.86K 615.42K 220.18K 209.57K 610.08K -222.22K -300.56K -487.58K -187.96K 351.23K 111.6K -1.2M
-13.53M -13.33M -13.11M 520.59K 462.24K 544.3K 456.44K 476.98K 429.2K 163.86K 29.63K 11.25K -65.7K -108.53K -93.85K -232.72K -108.49K -31.25K 10.03K 231.91K 198.9K 130.86K
– – – – – – – – – – – – – – – – – – – – – –
14.81M 14.81M 14.87M 1.45M 1.79M 1.85M 1.2M 674.18K 1.45M 770.68K -404.15K 231.25K -448.02K -215.59K 878.34K -41.98K -1.11M -260.66K 51.79K 602.31K 1.35M 45.08K
-140.49K 166.65K 148.26K 234.75K 392.15K 45.12K -466.36K -727.16K 327.08K 183.37K -699.69K -92.77K -880.93K -998.32K -409.55K -1.19M -1.86M -852.36K -249.84K 284.64K 511.1K -73.52K
-78.99K -111.55K -169.88K -436.96K -354.52K -350.04K -291.72K -23.39K -32.61K -4.53K -4.53K -149.41K -401.96K -577.26K -578.65K -436.29K -599.72K -439.45K -438.06K -198.43K -41.88K -519.51K
– – – – – – – – -60.47K -60.47K -60.47K -60.47K – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – –
-77.93K -77.93K -77.93K -325.92K -253.31K -253.31K -253.31K – -6.99K -2.49K 53.48K 230.16K 237.15K 232.65K 176.68K – – – – – – –
-78.99K -78.93K -137.25K -404.34K -321.89K -350.04K -291.72K -23.39K -100.07K -67.48K -11.52K 20.28K -164.82K -344.61K -401.96K -436.29K -599.72K -439.45K -438.06K -198.43K -41.88K -519.51K
-154.01K -296.53K -294.03K -214.63K -85.58K -56.32K 27.35K 50.93K -432.32K -438.24K 73.14K -629.3K -124.5K -975.99K -1.77M 3.52M 3.07M 4.47M 4.6M -33.81K -842.59K 584.51K
– – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – –
-154.01K -296.53K -294.03K -214.63K -85.58K -56.32K 27.35K 50.93K -432.32K -438.24K 73.15K -629.3K -124.5K -975.99K -1.77M 3.52M 3.07M 4.47M 4.6M -33.81K -842.59K 584.51K
-320.16K -244.21K -281.77K -451.07K -114.31K -426.19K -796.96K -651.18K -162.57K -328.07K -606.13K -716.43K -1.34M -2.55M -2.83M 1.63M 490.09K 3.18M 3.9M 112.22K -281.67K 57.56K
-219.48K 55.09K -21.62K -202.22K 37.64K -304.92K -758.08K -750.55K 287.48K 171.85K -711.2K -249.17K -1.28M -1.58M -988.19K -1.63M -2.46M -1.29M -687.9K 86.21K 469.22K -593.04K
-219.48K 55.09K -21.62K -202.22K 37.64K -304.92K -758.08K -750.55K 287.48K 171.85K -711.2K -327.44K -1.36M -1.65M -1.07M -1.63M -2.46M -1.29M -687.9K 86.21K 469.22K -593.04K
-73.23K -73.23K -131.55K -404.4K -321.96K -350.04K -291.72K -23.39K -32.61K -4.53K -4.53K -102.21K -354.76K -530.05K -531.44K -436.29K -599.72K -439.45K -438.06K -198.42K -5.67K 9.35K
-5.77K -38.33K -38.33K -32.56K -32.56K – – – – – – -47.21K -47.21K -47.21K -47.21K – – – -4 -4 -36.21K -528.86K
-213.72K 93.42K 16.71K -169.66K 70.2K -304.92K -758.08K -750.55K 294.47K 178.84K -704.21K -194.98K -1.24M -1.53M -940.99K -1.63M -2.46M -1.29M -687.89K 86.22K 505.43K -64.17K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.